Degenerative Disc Disease (DDD)
11
2
3
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
18.2%
2 terminated out of 11 trials
50.0%
-36.6% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
PMCF Study on the Effectiveness and Safety of METROSAN Spinal Systems and BONEGRAFT Filling Materials
PMCF Study to Evaluate the VERTICALE® Cervical System in Spine Surgery According to Its Intended Use.
INDUCE: A Prospective 2-Year Spine Registry
Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine
Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive
Freedom Lumbar Disc in the Treatment of Lumbar Degenerative Disc Disease
Luna Interbody System for Fusion Trial
Retrospective, Multicenter Clinical Evaluation of Health Economic Drivers and Complications for Two Lumbar Fusion Procedures
A Study Comparing Fusion Rates of Two Lumbar Fusion Procedures
Kineflex|C Artificial Disc System to Treat Cervical Degenerative Disc Disease (DDD)